Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)?

Blood

Volumn 115, Issue 12, 2010, Pages 2557-2558

  Batz, Christiane ^a   Hasle, Henrik ^b   Bergsträsser, Eva ^c   Van Den Heuvel Eibrink, Marry M ^d   Zecca, Marco ^e   Niemeyer, Charlotte M ^a   Flotho, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SPRED1 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; LEUKEMOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77950590613     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-12-260901     Document Type: Letter

References (8)

1. Pasmant E, Ballerini P, Lapillonne H, et al. SPRED1 disorder and predisposition to leukemia in children [letter]. Blood. 2009;114(5):1131.
2. Denayer E, de Ravel T, Legius E. Clinical and molecular aspects of RAS related disorders. J Med Genet. 2008;45(11):695-703.
3. Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007;39(9):1120-1126. (Pubitemid 47340658)
4. Flotho C, Kratz CP, Niemeyer CM. Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets. 2007;8(6):715-725. (Pubitemid 47603401)
5. Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34(2):148-150. (Pubitemid 36666923)
6. Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38(3):331-336. (Pubitemid 43315756)
7. Side L, Taylor B, Cayouette M, et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med. 1997;336(24):1713-1720. (Pubitemid 27251785)
8. Wakioka T, Sasaki A, Kato R, et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature. 2001;412(6847):647-651. (Pubitemid 32772277)